Cargando…
MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis
MicroRNA (miRNA) expression dysregulations in pancreatic ductal adenocarcinoma (PDAC) have been studied widely for their diagnostic and prognostic utility. By the use of bioinformatics-based methods, in our previous study, we identified some potential miRNA panels for diagnosis of pancreatic cancer...
Autores principales: | Seyed Salehi, Ali, Parsa-Nikoo, Negar, Roshan-Farzad, Farnaz, Shams, Roshanak, Fathi, Mohadeseh, Asaszadeh Aghdaei, Hamid, Behmanesh, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569215/ https://www.ncbi.nlm.nih.gov/pubmed/36254252 http://dx.doi.org/10.1155/2022/8040419 |
Ejemplares similares
-
MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells
por: Zhang, Tao, et al.
Publicado: (2017) -
Evaluation of MicroRNA92, MicroRNA638 in Acute Lymphoblastic Leukemia of Egyptian Children
por: Fayed, Dina, et al.
Publicado: (2021) -
MicroRNAs Targeting MYC Expression: Trace of Hope for Pancreatic Cancer Therapy. A Systematic Review
por: Shams, Roshanak, et al.
Publicado: (2020) -
MicroRNA-4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells
por: Jing, Li, et al.
Publicado: (2019) -
Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods
por: Shams, Roshanak, et al.
Publicado: (2020)